News

Pharmaceutical Technology26m
Japan’s MHLW approves Sarepta’s gene therapy for DMD
Japan’s MHLW has approved Sarepta Therapeutics’ gene therapy Elevidys for treating Duchenne muscular dystrophy (DMD) ...